Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.1200 (0.74%) ($7.9900 - $8.3500) on Mon. Mar. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.51% (three month average) | RSI | 43 | Latest Price | $8.1200(0.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(5%) TBT(3%) BLOK(2%) IBB(2%) KWEB(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.755% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.755% (StdDev 3.51%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $8.39 | 5 Day Moving Average | $8.18(-0.73%) | 10 Day Moving Average | $8.16(-0.49%) | 20 Day Moving Average | $8.39(-3.22%) | To recent high | -16.5% | To recent low | 15% | Market Cap | $1.433b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |